Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R. L. Kolotkin"'
Publikováno v:
Clinical obesity. 7(6)
Lorcaserin, plus diet and exercise, has demonstrated significant weight loss and improved cardiometabolic parameters vs. placebo in patients with overweight/obesity in three randomized, placebo-controlled trials. We examined whether lorcaserin is als
Publikováno v:
Clinical Obesity
Summary Existing measures of health‐related quality of life and patient functioning in obesity, such as the Impact of Weight on Quality of Life‐Lite (IWQOL‐Lite) questionnaire, lack the developmental rigour required by the Food and Drug Adminis
Publikováno v:
Clinical obesity. 5(5)
Weight loss is associated with improved quality of life in some, but not all, weight loss trials. We evaluated changes at 56 weeks in quality of life, measured by the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire, in a pooled an
Publikováno v:
Value in Health. 9(3)
Publikováno v:
The American journal of managed care. 7(9)
To determine whether (1) patients who experience greater weight loss also experience correspondingly greater improvements in health-related quality of life (HRQOL); (2) the improvement in HRQOL is noticeable for patients achieving moderate (5%-10%) w
Publikováno v:
Journal of consulting and clinical psychology. 55(6)
Publikováno v:
Value in Health. (6):A327